Reply to comment


June 28, 2019, 6:37 a.m. -  AJ Barlas

Yep, easy to access for sure. Perhaps because there wasn’t any official testing prior to last season riders and teams weren’t really considering it fully. They’re certainly aware now. On the TUE topic. From the PDF it seems to be required to have an approval prior to testing. > The detection in an Athlete’s Sample at all times or In-Competition, as applicable, of any quantity ofthe following substances subject to threshold limits: formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine, in conjunction with a diuretic or masking agent, will be considered as an Adverse Analytical Finding (AAF) **unless the Athlete _has_ an approved Therapeutic Use Exemption (TUE) for that substance** in addition to the one granted for the diuretic or masking agent.

Post your comment

Please log in to leave a comment.